Publications in collaboration with researchers from NewYork–Presbyterian Hospital (1)

2016

  1. Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma

    Blood, Vol. 128, Núm. 9, pp. 1174-1180